시장보고서
상품코드
1149669

세계의 재택 주입 요법 시장 규모 : 제품별, 용도별, 업계 분석, 지역 전망, 성장 가능성, 가격 동향, 경쟁 시장 점유율, 예측(2023-2032년)

Home Infusion Therapy Market Size By Product, By Application, Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2023 - 2032

발행일: | 리서치사: Global Market Insights Inc. | 페이지 정보: 영문 144 Pages | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 재택 주입 요법 시장은 외래 환자수 증가에 의해 2032년까지 크게 성장할 것으로 예측됩니다.

게다가 재택에서의 치료나 수술후 치료에 대한 선호 상승도 재택 주입 요법 기기 사용을 가속시키고 있습니다.

세계의 재택 주입 요법(Home Infusion Therapy) 시장에 대해 조사 분석했으며, 업계 인사이트, 부문 분석, 지역 분석, 기업 개요 등을 제공하고 있습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 재택 주입 요법 업계 인사이트

  • 업계 세분화
  • 업계 상황(2018-2032년)
  • 업계의 영향요인
    • 성장 촉진요인
    • 업계의 잠재적 위험·과제
  • 성장 가능성 분석
    • 제품별
    • 용도별
  • COVID-19의 영향 분석
  • 재택 주입 요법 업계 동향
  • 재택 주입 요법 업계 향후 전망
  • 규제 상황
    • 미국
    • 유럽
  • Porter's Five Forces 분석
  • PESTLE 분석

제4장 경쟁 상황(2021년)

  • 서론
  • 기업 매트릭스 분석(2021년)
  • 전략 대시보드(2021년)

제5장 재택 주입 요법 시장 : 제품별

  • 주요 부문 동향
  • 주입 펌프
  • 점적 세트
  • IV 캐뉼라
  • 무바늘 커넥터

제6장 재택 주입 요법 시장 : 용도별

  • 주요 부문 동향
  • 항감염증
  • 수분보급요법
  • 화학요법
  • 경장영양
  • 정맥영양
  • 특수 의약품
  • 기타

제7장 재택 주입 요법 시장 : 지역별

  • 주요 지역 동향
  • 북미
    • 시장 규모 : 국가별(2018-2032년)
    • 시장 규모 : 제품별(2018-2032년)
    • 시장 규모 : 용도별(2018-2032년)
    • 미국
    • 캐나다
  • 유럽
    • 시장 규모 : 국가별(2018-2032년)
    • 시장 규모 : 제품별(2018-2032년)
    • 시장 규모 : 용도별(2018-2032년)
    • 독일
    • 영국
    • 프랑스
    • 스페인
    • 이탈리아
  • 아시아태평양
    • 시장 규모 : 국가별(2018-2032년)
    • 시장 규모 : 제품별(2018-2032년)
    • 시장 규모 : 용도별(2018-2032년)
    • 중국
    • 일본
    • 인도
    • 호주
    • 한국
  • 라틴아메리카
    • 시장 규모 : 국가별(2018-2032년)
    • 시장 규모 : 제품별(2018-2032년)
    • 시장 규모 : 용도별(2018-2032년)
    • 브라질
    • 멕시코
  • 중동 및 아프리카
    • 시장 규모 : 국가별(2018-2032년)
    • 시장 규모 : 제품별(2018-2032년)
    • 시장 규모 : 용도별(2018-2032년)
    • 남아프리카공화국

제8장 기업 개요

  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton Dickinson and Company
  • Fresenius Kabi
  • ICU Medical Inc.
  • Terumo Corporation
  • Moog Inc.
  • Halyard Health, Inc.(Avanos Medical)
  • Amsino International, Inc.
  • Lepu Medical Technology
  • Erenler Medikal
  • Contec Medical Systems Co. Ltd
  • JMS Co. Ltd.
KSM 22.11.24

The home infusion therapy market is slated to grow at a substantial rate over 2032, owing to the rising number of outpatient visits. In addition, increasing preference for at-home treatment or post-surgery treatment are also accelerating the use of home infusion therapy devices. Patients that require long-term treatment mostly choose at-home therapy options.

A wide variety of home infusion therapies are available to treat different chronic illnesses. Specialty infusions are administered to patients with hemophilia, arthritis, congestive heart failure, Crohn's disease, multiple sclerosis (MS), high-risk pregnancy, and several immune deficiencies.

Rising prevalence of hormone disorders and rare diseases has fueled the need for drug therapies involving the administration of antibiotics, total parenteral nutrition (TPN), intravenous immunoglobulin (IVIG), and antivirals. To cope with side effects such as dehydration or soreness associated with intense treatments, physicians recommend home infusion therapy for pain management.

Technological advancements have enabled the development of next-generation smart infusion pumps as a part of clinical decision-support tools to ensure an accurate medication administration process. The advent of smart infusion pumps has enhanced accuracy and KVO with alarms, pressure control systems, and other smart features.

Leveraging recent healthcare trends such as smart diagnosis and treatment, telemedicine, and telehealth, various industry players are introducing novel home infusion devices. For instance, in August 2022, Baxter International Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new syringe infusion pump (SYR) called Novum IQ. With the Dose IQ Software and IQ Enterprise connectivity suite, SYR can effectively integrate with electronic medical records.

The home infusion therapy market is segregated into product, application, and region.

Based on product, the industry is classified into infusion pumps, needless connectors, intravenous sets, and IV cannulas. Home infusion therapy market share from the needless connectors segment is expected to go beyond USD 25 billion by 2032. Needleless connectors are widely used for central, arterial, and peripheral catheters.

Increasing use of needle-free connectors can be attributed to the advantages such as faster and safer access to the infusion line and reduced risk of accidental puncture and infection. These devices also help prevent contamination of patients' catheters and reduce the risk of device occlusion.

With respect to application, the home infusion therapy market is fragmented into chemotherapy, hydration therapy, specialty pharmaceuticals, anti-infective, hydration therapy, enteral nutrition, parenteral nutrition, and others. The industry share from the specialty pharmaceuticals segment is poised to reach over USD 10.5 billion by 2032.

Specialty drugs are administered via home infusion systems to treat complex and rare diseases through monitored dosage. The rising prevalence of chronic diseases is expected to propel the demand for home infusion devices for the administration of specialty drugs.

From a regional perspective, the Asia Pacific home infusion therapy market is anticipated to exhibit over 12% CAGR by 2032. The presence of a robust geriatric population, increasing cases of cancer, and a growing burden on healthcare will complement regional industry growth. APAC countries such as India and China are ramping up efforts to incorporate skilled healthcare experts by providing training and incentivizing younger doctors.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definitions
  • 1.2 Base estimates and working
  • 1.3 Forecast parameters
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 Home infusion therapy industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Product trends
    • 2.1.3 Application trends
    • 2.1.4 Regional trends

Chapter 3 Home Infusion Therapy Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2018 - 2032
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Growing hospital acquired infections
      • 3.3.1.2 Rising prevalence of chronic diseases
      • 3.3.1.3 Advancements in technology
      • 3.3.1.4 Growing geriatric population
      • 3.3.1.5 Increasing preference towards at-home healthcare solutions
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 Dearth of reimbursement
      • 3.3.2.2 Safety concerns and risk of failure associated with home infusion devices
  • 3.4 Growth potential analysis
    • 3.4.1 By product
    • 3.4.2 By application
  • 3.5 COVID- 19 impact analysis
  • 3.6 Trends in home infusion therapy industry
  • 3.7 Future prospects for home infusion therapy industry
  • 3.8 Regulatory landscape
    • 3.8.1 U.S.
    • 3.8.2 Europe
  • 3.9 Porter's analysis
    • 3.9.1 Industry rivalry
    • 3.9.2 Suppliers power
    • 3.9.3 Buyer power
    • 3.9.4 Threat of substitute
    • 3.9.5 Threat of new entrants
  • 3.10 PESTLE Analysis
    • 3.10.1 Political
    • 3.10.2 Economical
    • 3.10.3 Social
    • 3.10.4 Technological
    • 3.10.5 Legal
    • 3.10.6 Environmental

Chapter 4 Competitive Landscape, 2021

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2021
  • 4.3 Strategy dashboard, 2021

Chapter 5 Home Infusion Therapy Market, By Product

  • 5.1 Key segment trends
  • 5.2 Infusion pumps
    • 5.2.1 Market size, by region, 2018 - 2032 (USD Million)
  • 5.3 Intravenous sets
    • 5.3.1 Market size, by region, 2018 - 2032 (USD Million)
  • 5.4 IV Cannulas
    • 5.4.1 Market size, by region, 2018 - 2032 (USD Million)
  • 5.5 Needleless connectors
    • 5.5.1 Market size, by region, 2018 - 2032 (USD Million)

Chapter 6 Home Infusion Therapy Market, By Application

  • 6.1 Key segment trends
  • 6.2 Anti-infective
    • 6.2.1 Market size, by region, 2018 - 2032 (USD Million)
  • 6.3 Hydration therapy
    • 6.3.1 Market size, by region, 2018 - 2032 (USD Million)
  • 6.4 Chemotherapy
    • 6.4.1 Market size, by region, 2018 - 2032 (USD Million)
  • 6.5 Enteral nutrition
    • 6.5.1 Market size, by region, 2018 - 2032 (USD Million)
  • 6.6 Parenteral nutrition
    • 6.6.1 Market size, by region, 2018 - 2032 (USD Million)
  • 6.7 Specialty pharmaceuticals
    • 6.7.1 Market size, by region, 2018 - 2032 (USD Million)
  • 6.8 Others
    • 6.8.1 Market size, by region, 2018 - 2032 (USD Million)

Chapter 7 Home Infusion Therapy Market, By Region

  • 7.1 Key regional trends
  • 7.2 North America
    • 7.2.1 Market size, by country, 2018 - 2032 (USD Million)
    • 7.2.2 Market size, by product, 2018 - 2032 (USD Million)
    • 7.2.3 Market size, by application, 2018 - 2032 (USD Million)
    • 7.2.4 U.S.
      • 7.2.4.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.2.4.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.2.5 Canada
      • 7.2.5.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.2.5.2 Market size, by application, 2018 - 2032 (USD Million)
  • 7.3 Europe
    • 7.3.1 Market size, by country, 2018 - 2032 (USD Million)
    • 7.3.2 Market size, by product, 2018 - 2032 (USD Million)
    • 7.3.3 Market size, by application, 2018 - 2032 (USD Million)
    • 7.3.4 Germany
      • 7.3.4.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.3.4.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.3.5 UK
      • 7.3.5.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.3.5.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.3.6 France
      • 7.3.6.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.3.6.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.3.7 Spain
      • 7.3.7.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.3.7.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.3.8 Italy
      • 7.3.8.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.3.8.2 Market size, by application, 2018 - 2032 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Market size, by country, 2018 - 2032 (USD Million)
    • 7.4.2 Market size, by product, 2018 - 2032 (USD Million)
    • 7.4.3 Market size, by application, 2018 - 2032 (USD Million)
    • 7.4.4 China
      • 7.4.4.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.4.4.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.4.5 Japan
      • 7.4.5.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.4.5.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.4.6 India
      • 7.4.6.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.4.6.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.4.7 Australia
      • 7.4.7.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.4.7.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.4.8 South Korea
      • 7.4.8.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.4.8.2 Market size, by application, 2018 - 2032 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Market size, by country, 2018 - 2032 (USD Million)
    • 7.5.2 Market size, by product, 2018 - 2032 (USD Million)
    • 7.5.3 Market size, by application, 2018 - 2032 (USD Million)
    • 7.5.4 Brazil
      • 7.5.4.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.5.4.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.5.5 Mexico
      • 7.5.5.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.5.5.2 Market size, by application, 2018 - 2032 (USD Million)
  • 7.6 MEA
    • 7.6.1 Market size, by country, 2018 - 2032 (USD Million)
    • 7.6.2 Market size, by product, 2018 - 2032 (USD Million)
    • 7.6.3 Market size, by application, 2018 - 2032 (USD Million)
    • 7.6.4 South Africa
      • 7.6.4.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.6.4.2 Market size, by application, 2018 - 2032 (USD Million)

Chapter 8 Company Profiles

  • 8.1 B. Braun Melsungen AG
    • 8.1.1 Business Overview
    • 8.1.2 Financial Data
    • 8.1.3 Product Landscape
    • 8.1.4 Strategic Outlook
    • 8.1.5 SWOT Analysis
  • 8.2 Baxter International Inc.
    • 8.2.1 Business Overview
    • 8.2.2 Financial Data
    • 8.2.3 Product Landscape
    • 8.2.4 Strategic Outlook
    • 8.2.5 SWOT Analysis
  • 8.3 Becton Dickinson and Company
    • 8.3.1 Business Overview
    • 8.3.2 Financial Data
    • 8.3.3 Product Landscape
    • 8.3.4 Strategic Outlook
    • 8.3.5 SWOT Analysis
  • 8.4 Fresenius Kabi
    • 8.4.1 Business Overview
    • 8.4.2 Financial Data
    • 8.4.3 Product Landscape
    • 8.4.4 Strategic Outlook
    • 8.4.5 SWOT Analysis
  • 8.5 ICU Medical Inc.
    • 8.5.1 Business Overview
    • 8.5.2 Financial Data
    • 8.5.3 Product Landscape
    • 8.5.4 Strategic Outlook
    • 8.5.5 SWOT Analysis
  • 8.6 Terumo Corporation
    • 8.6.1 Business Overview
    • 8.6.2 Financial Data
    • 8.6.3 Product Landscape
    • 8.6.4 Strategic Outlook
    • 8.6.5 SWOT Analysis
  • 8.7 Moog Inc.
    • 8.7.1 Business Overview
    • 8.7.2 Financial Data
    • 8.7.3 Product Landscape
    • 8.7.4 Strategic Outlook
    • 8.7.5 SWOT Analysis
  • 8.8 Halyard Health, Inc. (Avanos Medical)
    • 8.8.1 Business Overview
    • 8.8.2 Financial Data
    • 8.8.3 Product Landscape
    • 8.8.4 Strategic Outlook
    • 8.8.5 SWOT Analysis
  • 8.9 Amsino International, Inc.
    • 8.9.1 Business Overview
    • 8.9.2 Financial Data
    • 8.9.3 Product Landscape
    • 8.9.4 Strategic Outlook
    • 8.9.5 SWOT Analysis
  • 8.10 Lepu Medical Technology
    • 8.10.1 Business Overview
    • 8.10.2 Financial Data
    • 8.10.3 Product Landscape
    • 8.10.4 Strategic Outlook
    • 8.10.5 SWOT Analysis
  • 8.11 Erenler Medikal
    • 8.11.1 Business Overview
    • 8.11.2 Financial Data
    • 8.11.3 Product Landscape
    • 8.11.4 Strategic Outlook
    • 8.11.5 SWOT Analysis
  • 8.12 Contec Medical Systems Co. Ltd
    • 8.12.1 Business Overview
    • 8.12.2 Financial Data
    • 8.12.3 Product Landscape
    • 8.12.4 Strategic Outlook
    • 8.12.5 SWOT Analysis
  • 8.13 JMS Co. Ltd.
    • 8.13.1 Business Overview
    • 8.13.2 Financial Data
    • 8.13.3 Product Landscape
    • 8.13.4 Strategic Outlook
    • 8.13.5 SWOT Analysis
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제